Pharmacists have long been the cornerstone of community healthcare, trusted by patients for their accessibility and personalized care. Now, they are poised to play a transformative role in clinical trials, addressing the most pressing challenges in drug development.
Clinical trials often struggle to meet recruitment targets and timelines, with 80% of trials failing to finish on time. Enter RxE2.
By integrating community pharmacies into the clinical trial ecosystem, RxE2 is reimagining how trials are conducted in the community. Through services like Direct Recruitment and Referral, Decentralized Trial Visits, and Clinical Trial Awareness campaigns, RxE2 connects trial sponsors with thousands of pharmacies, creating a streamlined, patient-centered approach.


“I’m a practicing pharmacist and independent community pharmacy owner for more than 30 years in NYC. My pharmacy and our other new participants never had such clinically relevant and meaningful revenue generating opportunities that RxE2 has introduced to our marketplace. Why hadn’t anyone in our industry thought of this concept sooner?” – Roger Paganelli RPh, Mt Carmel Pharmacy, New York
“I think you have to consider the fact that due to our accessibility and our relationship with the patients, we’re in the best position to identify potential candidates for clinical studies. For example, it could be a life-changing drug for the patient, and you could be a part of that.” – Bruno Tching, PharmD, RPh, Inland Pharmacy, California
“Working with RxE2 truly brings in wonderful cash flow, and it’s worth it. When owners see the revenue potential, like bringing in $5,000 or $10,000, they will support their staff’s engagement. It is absolutely doable.” – Jenna Eccles, RPh, Wheat Ridge Professional Pharmacy, Colorado


